Escuela de Medicina, Universidad Mayor, Santiago, Chile.
Servicio de Dermatología, Hospital del Salvador, Santiago, Chile.
Actas Dermosifiliogr (Engl Ed). 2021 Feb;112(2):118-126. doi: 10.1016/j.ad.2020.09.004. Epub 2020 Oct 10.
Researchers the world over are working to find the treatments needed to reduce the negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis of patients. Several drugs that are often used in dermatology are among the potentially useful treatments: ivermectin, antiandrogenic agents, melatonin, and the antimalarial drugs chloroquine and hydroxychloroquine. These and other agents, some of which have proven controversial, are being scrutinized by the scientific community. We briefly review the aforementioned dermatologic drugs and describe the most recent findings relevant to their use against COVID-19.
世界各地的研究人员正在努力寻找治疗方法,以减轻 2019 年冠状病毒病 (COVID-19) 的负面影响,改善患者的现有预后。皮肤科常用的几种药物也在潜在的有效治疗方法之列:伊维菌素、抗雄激素药物、褪黑素、抗疟药物氯喹和羟氯喹。这些和其他一些药物,其中一些已被证明存在争议,正受到科学界的审查。我们简要回顾了上述皮肤科药物,并描述了与它们在 COVID-19 治疗中的应用相关的最新发现。